The BiopSys team has already developed the technique to the point where it produces “a higher-fidelity, more sensitive measurement than in any existing commercial technology,” Walker says. “That’s a good first step. But that’s in a lab setting.” He hopes that companies will soon seek to license the technology, for which his team has made several patent applications. “The hope and expectation is that, as this technology develops, it gets translated onto end users – companies that will manufacture the devices, and doctors that will use them.” That could take another five to 10 years, he says.
Source: Prof Gilbert Walker Laboratory at the University of Toronto